Should rituximab be used to treat antineutrophil cytoplasmic antibody associated vasculitis?

Documents similaires

• Remission in antineutrophil cytoplasmic antibody-associated systemic vasculitis.
  par: Mukhtyar, C, et autres
  Publié: (2006)
• Cardiovascular outcomes in antineutrophil cytoplasm antibody associated vasculitis (AAV)
  par: Mukhtyar, C, et autres
  Publié: (2008)
• Is rituximab “The Wonder Drug” for antineutrophil cytoplasmic antibodies-associated vasculitis?
  par: Saket Jha, et autres
  Publié: (2019-01-01)
• Severe Infections following Rituximab Treatment in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
  par: Zhi-Ying Li, et autres
  Publié: (2020-08-01)
• A Case of Postcoronavirus Disease 2019 Antineutrophil Cytoplasmic Antibody-associated Vasculitis Successfully Treated with Rituximab
  par: Mahmoud M. Mohamed, et autres
  Publié: (2023-07-01)